Collectively, these findings suggest that Rab22A is a bona fide substrate for TBC1D31, and the TBC1D31‐Rab22A axis is responsible for reducing the endolysosomal trafficking of EGFR in HCC cells. This evidence concerns the gene RAB22A and hepatocellular carcinoma.